EQT is buying secondaries specialist Coller Capital for $3.2 billion, a major move into the growing market for private equity stakes. The deal gives the Swedish firm a significant platform in a sector where institutional investors increasingly seek liquidity for aging funds.
Carlyle's Robert Schmidt sees the Medline IPO as a sign that the IPO window is reopening for large private equity-backed companies. Medline's listing, backed by Blackstone, Carlyle, and Hellman & Friedman, could encourage other sponsors to pursue exits after a prolonged drought.
The broader market shows signs of thawing. Bridgepoint-owned ECP sold three Midwest power plants to a strategic buyer, while deal flow in the automotive sector is picking up in 2025. These moves suggest private equity firms are actively seeking liquidity through various channels as conditions improve.
Source: PE Hub · Summarized by HeadlinesBriefing